Clostridium difficile infection (CDI) is an important health problem with severe morbidity and
mortality. In our study, 266 adult patients admitted to the hospital between the years 2005 …

Nucleic acid amplification tests (NAATs) are reliable tools for the detection of toxigenic
Clostridium difficile from unformed (liquid or soft) stool samples. The objective of this study …

Background The aim of this study was to identify risk factors for Clostridium difficile infection
(CDI) and its attributable mortality and to propose methods to prevent CDI and improve …

Background Clostridium difficile infection (CDI) has increased in incidence and severity
worldwide, causing direct costs estimated to range from US 3.2billionto 4.8 billion. The aim …

Background Clostridium difficile infection (CDI) is the leading cause of hospital-acquired
diarrhoea in developed countries, however a high proportion of CDI episodes go …

Clostridium difficile infection (CDI) is one of the most common health‐care‐associated
infections and has become a crucial cause of morbidity and mortality in older patients, but …

Clostridium difficile (C. difficile) is a spore-forming, toxin-producing, gram-positive anaerobic
bacterium that is the principal etiologic agent of antibiotic-associated diarrhea. Infection with …

ABSTRACT A new molecular assay detecting toxigenic Clostridium difficile, the BD Max
Cdiff (Becton, Dickinson), was evaluated with 360 diarrheal feces samples. It exhibited high …

Clostridium difficile is the most common causal pathogen for both antibiotic associated and
nosocomial infectious diarrhoea. Clostridium difficile infection (CDI) in the intensive care unit …

Aim In this study, the prevalence of C. difficile, from patients with gastrointestinal complaints
and its association with other enteropathogen microbes were investigated. Background …